DeNovo Ventures

DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons

Business Model:

Revenue: $16.8M

Employees: 11-50

Rankings

Detailed DeNovo Ventures Information

Geographic Data

DeNovo Ventures headquarters map

Address: 14612 Big Basin Way

City: Saratoga

State: CA

Zip: 95070

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

5,151,630Website Global Rank

1,758Website Monthly Traffic

Twitter Followers

Description

DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth – from early stage to late stage. The unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.

Contact Phone:
+16503291999

Contact Email:

Announced Date Company Transaction Money Raised
1/2007 TearScience Series B 15.1M
1/2023 Milo Series A 0
1/2008 Benvenue Medical Series B 15M
5/2005 Talima Therapeutics Series A 1.6M
11/2009 EndoGastric Solutions Series E 0
10/2009 EndoGastric Solutions Venture Round 0
6/2012 EndoGastric Solutions Venture Round 0
3/2013 Avedro Series D 0
4/2012 EndoGastric Solutions Venture Round 0
5/2008 Astute Medical Series A 6.3M
7/2006 InSound Medical Series E 18.9M
11/2009 Spinal Modulation Series C 27.4M
6/2012 Benvenue Medical Series D 25M
2/2008 InSound Medical Series E 11M
12/2007 AxoGen Post-IPO Equity 12.1M
6/2014 Benvenue Medical Series E 40M
4/2003 iScience Interventional Series C 15M
7/2007 CardioMind Series C 11M
3/2008 CardioMind Venture Round 22M
12/2009 EBR Systems Venture Round 15M
3/2004 Spinal Kinetics Series A 10M
2/2009 SynergEyes Series C 0
10/2005 EBR Systems Series B 21M
11/2007 Viracta Therapeutics Series A 20M
10/2008 InSound Medical Series E 13M
3/2006 Cartilix Series B 6.3M
4/2010 Viracta Therapeutics Series B 12M
10/2007 Vitreoretinal Technologies Series A 12M
3/2004 InSound Medical Series D 17.2M
11/2005 FlowMedica Series D 0
4/2010 Articulinx Inc. Series B 10M
3/2011 Astute Medical Series B 13M
3/2012 Viracta Therapeutics Series B 0
7/2008 Sierra Surgical Series B 14.5M
8/2007 Sierra Surgical Series A 7.1M
11/2005 Ovalis Series A 0
5/2007 Pulmonx Series B 20M
3/2003 iScience Surgical Series B 0
2/2011 EBR Systems Series D 5M
6/2004 EBR Systems Series A 5.2M
5/2010 Astute Medical Series B 26.5M
10/2005 PhotoThera Series B 19M
8/2001 MicroVention Terumo Series C 12.5M
9/2011 Simpirica Spine Series C 22M
7/2008 MyoScience Series B 0
9/2013 MyoScience Series E 0
3/2012 MyoScience Series D 0
6/2009 Facet Solutions Debt Financing 4.1M
6/2004 Paracor Medical Series C 30.5M
6/2007 Paracor Medical Series D 44M
8/2007 EndoGastric Solutions Series D 30M
1/2016 Benvenue Medical Equity 23M
6/2011 Spinal Modulation Series D 0
5/2009 PhotoThera Series D 50M
7/2003 Bacchus Vascular Series D 25M
5/2007 Talima Therapeutics Series B 19M
5/2014 EndoGastric Solutions Series G 0
4/2006 PhotoThera Series C 30.5M
4/2006 SynergEyes Series B 0
4/2017 Avedro Venture Round 0
6/2008 EBR Systems Series C 35M
5/2007 TRIA Beauty Series D 0
11/2008 OncoMed Pharmaceuticals Series B 154M
5/2009 iScience Interventional Series F 20.5M
1/2006 Spinal Kinetics Series B 36M
5/2005 Bayhill Therapeutics Series B 35.4M
1/2002 Renovis Series B 0
3/2005 iScience Surgical Series C 0
12/2005 Facet Solutions Series B 16.5M
1/2008 Avedro Series A 8M
2/2011 Spiracur Series C 35M
2/2011 TRIA Beauty Venture Round 26.3M
4/2012 WaveTec Vision Venture Round 0
1/2003 Lumend Series D 23.2M
1/2012 iScience Interventional Venture Round 2.8M
5/2010 TearScience Series C 44.5M
9/2009 Spinal Kinetics Debt Financing 5.3M
4/2016 TearScience Series D 0
1/2008 POINT Biomedical Private Equity Round 0
10/2012 TRIA Beauty Venture Round 7.5M
7/2013 TRIA Beauty Private Equity Round 0
4/2006 Bayhill Therapeutics Venture Round 15.8M
2/2009 WaveTec Vision Series C 20.1M
5/2011 WaveTec Vision Series D 15.9M
5/2007 WaveTec Vision Series B 13M
4/2011 Benvenue Medical Series C 35.5M
8/2010 EndoGastric Solutions Series F 0
6/2009 EndoGastric Solutions Venture Round 3.8M
6/2012 Astute Medical Series C 40.4M
1/2006 Spinal Modulation Series A 7M
3/2010 Pulmonx Series C 0
6/2014 Spinal Kinetics Venture Round 34M
6/2009 Spiracur Series B 20.3M
1/2012 Pulmonx Private Equity Round 0
5/2018 Avedro Series F 0
1/2007 Ovalis Series B 0
5/2018 Avedro Series F 0
4/2017 Avedro Venture Round 0
4/2016 TearScience Series D 0
1/2016 Benvenue Medical Series F 0
6/2014 Benvenue Medical Series E 0
6/2014 Spinal Kinetics Venture Round 0
5/2014 EndoGastric Solutions Series G 0
9/2013 MyoScience Series E 0
7/2013 TRIA Beauty Private Equity Round 0
3/2013 Avedro Series D 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research